SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/F2EC7332CF879E0216E21CBA13F36F812C5C61406BF37725188708E95B4A8281704EFBC05603966B0921602427F99BB8>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/F2EC7332CF879E0216E21CBA13F36F812C5C61406BF37725188708E95B4A8281704EFBC05603966B0921602427F99BB8
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/F2EC7332CF879E0216E21CBA13F36F812C5C61406BF37725188708E95B4A8281704EFBC05603966B0921602427F99BB8
http://www.w3.org/2000/01/rdf-schema#comment
"Antroquinonol may have therapeutic potential for the early treatment of ASLN via its differential regulation of T cell function and lowering of IL-18 production but also via the promotion of Nrf2 activation."
xsd:string
http://purl.uniprot.org/uniprot/#_51B724306CCFD387F66F762F437657F5F462783732FA63D185A435B5BB347A25D527951A959F31E0C7746B926B6BA4B1
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/F2EC7332CF879E0216E21CBA13F36F812C5C61406BF37725188708E95B4A8281704EFBC05603966B0921602427F99BB8
http://purl.uniprot.org/uniprot/Q80SS8
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/F2EC7332CF879E0216E21CBA13F36F812C5C61406BF37725188708E95B4A8281704EFBC05603966B0921602427F99BB8
http://purl.uniprot.org/uniprot/#_Q80SS8-mappedCitation-21905011
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/F2EC7332CF879E0216E21CBA13F36F812C5C61406BF37725188708E95B4A8281704EFBC05603966B0921602427F99BB8